Peter Wehrwein

Yale-developed, NBA-funded saliva test costing $10 per test could make frequent testing of asymptomatic people feasible.

In this part two of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.

In this part one of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.

Excess deaths associated with the two pandemics are in the same ballpark during New York City peaks.

Harris ended up proposing a moderate Medicare for all plan modeled on the Medicare Advantage choice that seniors now have.

Colcrys and Copaxone are among the exceptions.

In this part two of two video series Adam Block discusses his recent article, “Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates.”

In this part one of two video series, Adam Block, a New York Medical College assistant professor, discusses his recent contributed article to Managed Healthcare Executive titled "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates."

In this part two of two series, Carolyn Langer, M.D., Fallon Health's chief medical officer, talks about Collective Medical and the advantages of real-time notifications of member hospital admissions and discharges and emergency department visits.

This week on Tuning Into The C-Suite, Managed Healthcare Executive Senior Editor Peter Wehrwein speaks with Assistant Professor of Public Health at New York Medical College, Adam Block. The two discuss Block's recent article published in MHE, "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates" and more.

Research model shows that caps on out-of-pocket costs don't result in higher health plan spending.

In this part one of two series, Carolyn Langer, M.D., the chief medical officer, says the Massachusetts health plan mounted a big push on telehealth that includes in-person visit payment levels.

It's early days yet because patent and other issues have kept FDA-approved biosimilars off the market, but Gary Lyman, M.D., M.P.H.. of the Fred Hutchinson Cancer Research Center says there's evidence of some effect on the price of cancer supportive drugs.

Underrepresentation of blacks in clinical trials is garnering special attention.

Study allays some concern that high-deductible health plans cause people to put off care, although authors urge caution in interpreting the results.

A small study shows that "photobiomodulation" with red light results in improved color vision in people that are 40 and older. The light may improve the function of mitochondria.

University of Michigan researchers developed a simple algorithm to guide risk-benefit decisions for glaucoma patient coming in for visits.

A minority camp of MS researchers argue that the disease may begin within pathologically processes within the central nervous system.

Study published in Annals of Neurology shows about half of RIS patients have a clinical event that typifies MS within 10 years.

Families USA estimates that 1 in 7 adult Americans don't have health insurance.

Jim Beiermann, CFO, and Danny Irland, senior vice president of network operations and chief network officer of Southwestern Health Resources discuss their focus of value-based care through ACO and Next Generation Programs within the company with Managed Healthcare Executive Senior Editor, Peter Wehrwein.

Study of program in Oregon suggests that fee-for-service may be the reason for the underwhelming results for patient-centered medical homes.

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Vote in May made FDA-approved biosimilars an "appropriate substitution" for brand-name biologics in NCCN guidelines.

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

In this week's episode of Tuning Into The C-Suite podcast, Senior Editor Peter Wehrwein has a conversation with John "Jack" Linehan, a lawyer for Epstein Becker Green, about coupons and accumulators. Jack is an expert on drug distribution and reimbursement, and few people know as much about coupons and accumulators as he does. Peter and Jack go over some of the basics, who is advantaged and disadvantaged, and then dive into some the details on CMS regulations and how recent proposed changes to Medicaid best price rules would, if finalized, affect coupons and accumulators.

Excerpts from our interview of Lisa Griffin, senior vice president of front-end operation, at Jefferson Health,